Chan CH - Search Results

1

A luminescent sensor for investigating serotonin metabolism in neuroendocrine cancer.

Tow DH, Chan CH, Howe JR, Ear PH. Tow DH, et al. Among authors: chan ch. Surgery. 2024 Mar;175(3):726-734. doi: 10.1016/j.surg.2023.09.018. Epub 2023 Oct 31. Surgery. 2024. PMID: 37914574

2

Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.

Beck AC, Rajan A, Landers S, Kelley S, Bellizzi AM, Lal G, Sugg SL, Howe JR, Chan CH, Weigel RJ. Beck AC, et al. Among authors: chan ch. Surgery. 2022 Jan;171(1):245-251. doi: 10.1016/j.surg.2021.03.076. Epub 2021 Aug 3. Surgery. 2022. PMID: 34362588

3

Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.

Beyer GV, Hueser S, Li R, Manika D, Lee M, Chan CHF, Howe JR, Ear PH. Beyer GV, et al. Surgery. 2024 Mar;175(3):605-612. doi: 10.1016/j.surg.2023.08.044. Epub 2023 Oct 31. Surgery. 2024. PMID: 37914572

4

Management of pancreatic intraductal papillary mucinous neoplasm.

Hoshi H, Zaheer A, El Abiad RG, Maxwell JE, Chu LC, Gerke H, Chan CH. Hoshi H, et al. Among authors: chan ch. Curr Probl Surg. 2018 Apr;55(4):126-152. doi: 10.1067/j.cpsurg.2018.03.001. Epub 2018 Mar 14. Curr Probl Surg. 2018. PMID: 29753366 No abstract available.

5

Retrospective study of testosterone deficiency and symptom burden in patients with pancreatic cancer.

Kazarian AG, Conger HK, Mott SL, Loeffler BT, Dempewolf SM, Coleman KL, Pearlman AM, Chan CHF, Talbert EE. Kazarian AG, et al. Transl Androl Urol. 2023 Jul 31;12(7):1079-1089. doi: 10.21037/tau-22-684. Epub 2023 Jul 28. Transl Androl Urol. 2023. PMID: 37554534 Free PMC article.

6

Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology.

Kruspe S, Dickey DD, Urak KT, Blanco GN, Miller MJ, Clark KC, Burghardt E, Gutierrez WR, Phadke SD, Kamboj S, Ginader T, Smith BJ, Grimm SK, Schappet J, Ozer H, Thomas A, McNamara JO 2nd, Chan CH, Giangrande PH. Kruspe S, et al. Among authors: chan ch. Mol Ther Nucleic Acids. 2017 Sep 15;8:542-557. doi: 10.1016/j.omtn.2017.08.004. Epub 2017 Aug 12. Mol Ther Nucleic Acids. 2017. PMID: 28918054 Free PMC article.

7

[No title available]

[No authors listed] [No authors listed] PMID: 37423929

8

Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.

Leick KM, Tomanek-Chalkley A, Coleman KL, Chan CHF. Leick KM, et al. Ann Surg Oncol. 2023 Oct;30(11):6652-6660. doi: 10.1245/s10434-023-13701-2. Epub 2023 Jun 11. Ann Surg Oncol. 2023. PMID: 37303025

9

Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma.

Chang J, Liu Y, Saey SA, Chang KC, Shrader HR, Steckly KL, Rajput M, Sonka M, Chan CHF. Chang J, et al. Front Oncol. 2022 Dec 8;12:895515. doi: 10.3389/fonc.2022.895515. eCollection 2022. Front Oncol. 2022. PMID: 36568148 Free PMC article.

10

CHEK2 Founder Variants and Thyroid Cancer Risk.

Brock P, Liynarachchi S, Nieminen TT, Chan C, Kohlmann W, Stout LA, Yao S, La Greca A, Jensen KE, Kolesar JM, Salhia B, Gulhati P, Hicks JK, Ringel MD. Brock P, et al. Thyroid. 2024 Apr;34(4):477-483. doi: 10.1089/thy.2023.0529. Epub 2024 Feb 27. Thyroid. 2024. PMID: 38279823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

952 results

Search Page